Tibet Rhodiola Pharmaceutical Holding Co.SSE: 600211

Announcement on Outline of the Q3 2025 Performance Briefing

· Issued by Tibet Rhodiola Pharmaceutical Holding Co. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

The company held an interactive performance briefing on December third, where executives addressed investor questions about recent sales and market conditions. The announcement includes responses to investor inquiries about revenue declines and future growth strategies. The company aims to enhance its profitability through various initiatives, including increased research and development efforts.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Tibet Rhodiola Pharmaceutical Holding Co. on 6ix

Earlier from Tibet Rhodiola Pharmaceutical

Later from Tibet Rhodiola Pharmaceutical

All Tibet Rhodiola Pharmaceutical news releases